This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: John Jiang - Innovator in Glycosyltransferase Inhibitors
Introduction
John Jiang is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of UDP glycosyltransferase inhibitors. His work focuses on creating compounds that can be used in treating various diseases.
Latest Patents
John Jiang holds a patent for UDP glycosyltransferase inhibitors and methods of use. The patent describes a compound of Formula (I) and its pharmaceutically acceptable salts. Additionally, it outlines compositions and their applications in treating diseases such as Krabbe's Disease (KD) and Metachromatic leukodystrophy (MLD).
Career Highlights
John Jiang is currently employed at Genzyme Corporation, where he continues to innovate in the pharmaceutical industry. His work has the potential to impact the treatment of serious genetic disorders.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues, including Sungtaek Lim and Robert H Barker, Jr. These partnerships have enhanced his research and development efforts.
Conclusion
John Jiang is a dedicated inventor whose work in glycosyltransferase inhibitors is paving the way for new treatments for critical diseases. His contributions to the field are invaluable and demonstrate the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile